We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$4.76B
AUM Growth
-$301M
Cap. Flow
-$879M
Cap. Flow %
-18.47%
Top 10 Hldgs %
31.51%
Holding
169
New
40
Increased
23
Reduced
18
Closed
45

Top Buys

Rank Stock Value
1
EWTX icon
Edgewise Therapeutics
EWTX
+$128M
2
BSX icon
Boston Scientific
BSX
+$108M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$89.6M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$76M
5
TOI icon
The Oncology Institute
TOI
+$53.3M

Top Sells

Rank Stock Value
1
NKTX icon
Nkarta
NKTX
+$87.3M
2
SWTX
SpringWorks Therapeutics
SWTX
+$69.3M
3
OSH
Oak Street Health, Inc.
OSH
+$58.2M
4
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
+$56.1M
5
DFHTU
Deerfield Healthcare Technology Acquisitions Corp. Unit
DFHTU
+$50.4M

Sector Composition

Rank Sector Weight
1 Healthcare 70.89%
2 Consumer Discretionary 0.23%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRCL
101
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$6.16M 0.13%
+400,000
New +$9.44M
FTH
102
Faeth Therapeutics
FTH
$733M
$5.45M 0.11%
+18,750
New +$6.28M
XENT
103
DELISTED
Intersect ENT, Inc
XENT
$5.33M 0.11%
255,456
– –
CABA icon
104
Cabaletta Bio
CABA
$435M
$5.15M 0.11%
464,252
– –
OHPAU
105
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$5M 0.11%
+500,000
New +$5.01M
CHFW.U
106
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$4.88M 0.1%
500,000
– –
BFLY.WS
107
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$4.73M 0.1%
+733,333
New +$5.99M
LUMO
108
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$4.37M 0.09%
373,117
-563,174
-60% -$9.47M
LABP
109
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$4.33M 0.09%
+45,000
New +$5.87M
MTCR
110
DELISTED
Metacrine, Inc. Common Stock
MTCR
$1.72M 0.04%
277,469
– –
TOIIW
111
The Oncology Institute Warrant
TOIIW
$4.45M
$1.69M 0.04%
+1,250,000
New +$2.32M
CMAXW
112
DELISTED
CareMax, Inc. Warrant
CMAXW
$1.55M 0.03%
+672,000
New +$2.37M
CEREW
113
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$718K 0.02%
166,666
– –
ELVN icon
114
Enliven Therapeutics
ELVN
$3.75B
$671K 0.01%
19,866
-124,601
-86% -$6.33M
NUVB.WS
115
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$445K 0.01%
+166,666
New +$482K
WINT
116
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
ALGS icon
117
Aligos Therapeutics
ALGS
$25.8M
– –
-24,000
Closed -$16.6M
ARVN icon
118
Arvinas
ARVN
$520M
– –
-75,000
Closed -$6.37M
BMRN icon
119
BioMarin Pharmaceuticals
BMRN
$12B
– –
-163,000
Closed -$14.3M
EDIT icon
120
Editas Medicine
EDIT
$396M
– –
-538,721
Closed -$37.8M
KOD icon
121
Kodiak Sciences
KOD
$2.58B
– –
-202,406
Closed -$29.7M
MASS icon
122
908 Devices
MASS
$283M
– –
-75,000
Closed -$4.27M
NKTX icon
123
Nkarta
NKTX
$160M
– –
-1,419,872
Closed -$87.3M
OM icon
124
Outset Medical
OM
$82.1M
– –
-11,667
Closed -$9.95M
OSUR icon
125
OraSure Technologies
OSUR
$271M
– –
-2,124,515
Closed -$22.5M
2 3 4
5
6

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2021 Portfolio in Review

As of Q1 2021, Deerfield Management held 169 positions worth $4.76B, down 6% from $5.06B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Deerfield Management withdrew a net $879M in Q1 2021, closing 45 positions and reducing 18 holdings. Its most notable exit was Nkarta, an estimated $87.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 70% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Deerfield Management opened a new position in Edgewise Therapeutics worth $128M.

  • Deerfield Management's largest Q1 2021 buy was Edgewise Therapeutics: 3,933,137 shares worth $128M.
  • Deerfield Management added most to The Oncology Institute in Q1 2021, an estimated $53.3M increase.
  • Deerfield Management's biggest Q1 2021 reduction was SpringWorks Therapeutics, cutting an estimated $69.3M.
  • Deerfield Management fully exited Nkarta in Q1 2021, selling an estimated $87.3M.
  • Deerfield Management's ten largest holdings make up 32% of its $4.76B portfolio in Q1 2021.
  • Deerfield Management opened 40 new positions and closed 45 in Q1 2021.
  • Deerfield Management's portfolio value fell 6% quarter-over-quarter to $4.76B.

Based on Deerfield Management's 13F filing for Q1 2021, filed 17 May 2021.